Sugi Predict

Sugi Predict / Compounds / SCHEMBL2496569

SCHEMBL2496569

SCHEMBL2496569

Cc1ccc(-c2nc(C)c(C)o2)c(C(=O)O)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.39
▸ HSD17B10 Q99714 4/20 0.39
▸ USP2 O75604 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ CA12 O43570 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CXCR4 P61073 1/20 0.34
▸ HCRTR1 O43613 1/20 0.34
▸ HCRTR2 O43614 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2493515 0.77 HCRTR1 (0.54) GAAHSD17B10USP2POLBMAPT
SCHEMBL16042101 0.76 HCRTR2 (0.41) USP2MAPTTSHRPDE4BKDM4E
SCHEMBL16031447 0.75 HCRTR2 (0.44) MAPTTSHRKDM4EALDH1A1HCRTR1
SCHEMBL609369 0.75 KMT2A (0.47) GAAUSP2MAPTTSHRKDM4E
SCHEMBL3389561 0.73 DHODH (0.35) POLBKDM4EMEN1KMT2A
SCHEMBL2495796 0.73 PDE4B (0.38) PDE4B
SCHEMBL3389553 0.73 HCRTR2 (0.40) GAAHSD17B10TSHRKDM4EALDH1A1
SCHEMBL610009 0.71 PIN1 (0.49) HSD17B10USP2POLBMAPTTSHR
SCHEMBL11381734 0.71 ALDH1A1 (0.49) GAAHSD17B10USP2MAPTTSHR
SCHEMBL2476367 0.70 HCRTR2 (0.42) HSD17B10USP2MAPTHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370426-A1 N-{[(IR,4S,6R-3-(2-PYRIDINYLCARBONYL)-3-AZABICYCLO [4.1.0]HEPT-4-YL]METHYL}-2-HETEROARYLAMINE DERIVATIVES AND USES THEREOF Glaxo Group Limited (GB) 2011-10-05 — — EP disclosed
US-20100144760-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2010-06-10 — — US disclosed
US-20100144760-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2010-06-10 — — US disclosed
WO-2010063663-A1 N-{[(IR,4S,6R-3-(2-PYRIDINYLCARBONYL)-3-AZABICYCLO [4.1.0]HEPT-4-YL] METHYL}-2-HETEROARYLAMINE DERIVATIVES AND USES THEREOF GLAXO GROUP LIMITED (GB) 2010-06-10 — — WO disclosed
WO-2010063663-A1 N-{[(IR,4S,6R-3-(2-PYRIDINYLCARBONYL)-3-AZABICYCLO [4.1.0]HEPT-4-YL] METHYL}-2-HETEROARYLAMINE DERIVATIVES AND USES THEREOF GLAXO GROUP LIMITED (GB) 2010-06-10 — — WO disclosed
US-20100144760-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2010-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144760-A1 NOVEL COMPOUNDS HTR3B, HTR1B, HTR2B GAA 1250/4885HSD17B10 2206/4885USP2 4322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.